日本語English简体中文 繁體中文

02595 GenFleet Therapeutics (Shanghai) Inc.GENFLEET-BHong Kong Stock Exchange (H-share)

12 posts

GenFleet Therapeutics (Shanghai) Inc. (02595) at a glance

Code
02595
Company
GenFleet Therapeutics (Shanghai) Inc.
Local name
GENFLEET-B
Market
Hong Kong Stock Exchange (H-share)
Share price
HK$23.82 +0.14 (+0.59%) Nov 12 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

GenFleet Therapeutics (Shanghai) Inc. (02595) Stock Price History

GenFleet Therapeutics (Shanghai) Inc. closed at HK$23.82 on Nov 12, 2026, −13.7% over 1 month, −17.7% over 1 year.

2026-10-15 事業の状況 VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Ach…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT Initial Clinical Readout of GFH276 (an Oral M…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of …2026-11-08 その他 SHARE REPURCHASE / 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…HK$30.80HK$18.76Oct 12Nov 12
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$30.80Oct 21
1-Month LowHK$18.76Nov 3
1-Week Change+0.2%vs Nov 5
1-Month Change−13.7%vs Oct 12

If you had invested HK$10,000 1 month ago, it would be worth HK$8,630 today (−13.7%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −1.1%, while this stock moved −13.7%.

Last 10 Trading Days

DateCloseChange% Change
Nov 12 (Thu)HK$23.82+0.14+0.59%
Nov 11 (Wed)HK$23.68−0.28−1.17%
Nov 10 (Tue)HK$23.96+1.44+6.39%
Nov 9 (Mon)HK$22.52+0.72+3.30%
Nov 6 (Fri)HK$21.80−1.98−8.33%
Nov 5 (Thu)HK$23.78+2.40+11.23%
Nov 4 (Wed)HK$21.38+2.62+13.97%
Nov 3 (Tue)HK$18.76−2.00−9.63%
Nov 2 (Mon)HK$20.76−1.74−7.73%
Oct 30 (Fri)HK$22.50−2.46−9.86%
2026-09-15 事業の状況 VOLUNTARY ANNOUNCEMENT Favorable Phase II Efficacy Data of GFH375 (O…2026-09-16 中間報告書 2026 Interim Report2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…2026-09-22 Unusual Price/Turnover Movements - Qualified ANNOUNCEMENT PURSUANT TO RULE 13.1…2026-09-23 事業の状況 VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data fro…2026-09-24 取締役・重要な執行役員の異動 RESIGNATION OF NON-EXECUTIVE DIRECTOR / 取締役一覧と役割 LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2026-10-15 事業の状況 VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Ach…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT Initial Clinical Readout of GFH276 (an Oral M…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of …2026-11-08 その他 SHARE REPURCHASE / 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…HK$34.38HK$18.76Aug 12Nov 12
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$34.38Aug 25
3-Month LowHK$18.76Nov 3
1-Month Change−13.7%vs Oct 12
3-Month Change−21.6%vs Aug 12

If you had invested HK$10,000 3 months ago, it would be worth HK$7,836 today (−21.6%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −5.6%, while this stock moved −21.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 12 (Thu)HK$23.82+0.14+0.59%
Nov 11 (Wed)HK$23.68−0.28−1.17%
Nov 10 (Tue)HK$23.96+1.44+6.39%
Nov 9 (Mon)HK$22.52+0.72+3.30%
Nov 6 (Fri)HK$21.80−1.98−8.33%
Nov 5 (Thu)HK$23.78+2.40+11.23%
Nov 4 (Wed)HK$21.38+2.62+13.97%
Nov 3 (Tue)HK$18.76−2.00−9.63%
Nov 2 (Mon)HK$20.76−1.74−7.73%
Oct 30 (Fri)HK$22.50−2.46−9.86%
2026-09-15 事業の状況 VOLUNTARY ANNOUNCEMENT Favorable Phase II Efficacy Data of GFH375 (O…2026-09-16 中間報告書 2026 Interim Report2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…2026-09-22 Unusual Price/Turnover Movements - Qualified ANNOUNCEMENT PURSUANT TO RULE 13.1…2026-09-23 事業の状況 VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data fro…2026-09-24 取締役・重要な執行役員の異動 RESIGNATION OF NON-EXECUTIVE DIRECTOR / 取締役一覧と役割 LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2026-10-15 事業の状況 VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Ach…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT Initial Clinical Readout of GFH276 (an Oral M…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of …2026-11-08 その他 SHARE REPURCHASE / 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…HK$42.40HK$18.76May 12Nov 12
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$42.40Jul 15
6-Month LowHK$18.76Nov 3
3-Month Change−21.6%vs Aug 12
6-Month Change−38.0%vs May 12

If you had invested HK$10,000 6 months ago, it would be worth HK$6,200 today (−38.0%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −8.9%, while this stock moved −38.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$23.82+5.9%
Oct 2026HK$22.50−31.8%
Sep 2026HK$33.00+7.1%
Aug 2026HK$30.80+11.0%
Jul 2026HK$27.74−5.8%
Jun 2026HK$29.44−13.7%
May 2026HK$34.12−20.9%
2026-09-15 事業の状況 VOLUNTARY ANNOUNCEMENT Favorable Phase II Efficacy Data of GFH375 (O…2026-09-16 中間報告書 2026 Interim Report2026-09-21 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…2026-09-22 Unusual Price/Turnover Movements - Qualified ANNOUNCEMENT PURSUANT TO RULE 13.1…2026-09-23 事業の状況 VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data fro…2026-09-24 取締役・重要な執行役員の異動 RESIGNATION OF NON-EXECUTIVE DIRECTOR / 取締役一覧と役割 LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2026-10-15 事業の状況 VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Ach…2026-10-26 事業の状況 VOLUNTARY ANNOUNCEMENT Initial Clinical Readout of GFH276 (an Oral M…2026-11-04 事業の状況 VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of …2026-11-08 その他 SHARE REPURCHASE / 事業の状況 VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurch…HK$49.46HK$18.76Nov 12Nov 12
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$49.46Apr 24
52-Week LowHK$18.76Nov 3
Year to Date+0.0%vs Dec 31
From 52-Week High−51.8%Apr 24

If you had invested HK$10,000 1 year ago, it would be worth HK$8,231 today (−17.7%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −10.8%, while this stock moved −17.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026HK$23.82+5.9%
Oct 2026HK$22.50−31.8%
Sep 2026HK$33.00+7.1%
Aug 2026HK$30.80+11.0%
Jul 2026HK$27.74−5.8%
Jun 2026HK$29.44−13.7%
May 2026HK$34.12−20.9%
Apr 2026HK$43.14+29.1%
Mar 2026HK$33.42+22.0%
Feb 2026HK$27.40−10.7%
Jan 2026HK$30.70+28.9%
Dec 2025HK$23.82−16.9%
Nov 2025HK$28.66―
HK$49.46HK$21.80Sep 15, 2025Nov 12, 2026
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$49.46Apr 24, 2026
3-Year LowHK$21.80Nov 6, 2026
Annualized Return−38.8%
Max Drawdown−55.9%

If you had invested HK$10,000 3 years ago, it would be worth HK$5,658 today (−43.4%).Price change only; dividends and fees are not included.

Over the same period the Hang Seng Index moved −9.6%, while this stock moved −43.4%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)HK$23.82+0.0%
2025HK$23.82―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Sep 2025). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.12 Disclosure 2026/11/09 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurchase
Delete
No.11 Disclosure 2026/11/08 19:11
その他
SHARE REPURCHASE
Delete
No.10 Disclosure 2026/11/04 08:30
事業の状況
VOLUNTARY ANNOUNCEMENT Multiple Innovative Combination Therapies of Oral Pan RAS Inhibitor GFH276 Recently Granted with Clinical Trial Approvals for First-line and Late-line Clinical Studies Addressing Major Tumor Indications in China or Abroad
Delete
No.9 Disclosure 2026/10/26 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT Initial Clinical Readout of GFH276 (an Oral Molecular-glue Pan RAS Inhibitor) Presented as Late-breaking Abstract (LBA) at 2026 ESMO Annual Meeting, Demonstrating Promising Clinical Potential and Favorable Safety in Pretreated RAS-mutant Solid Tumors
Delete
No.8 Disclosure 2026/10/15 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT GFH375/VS-7375 (Oral KRAS G12D Inhibitor) Achieves Positive Progress across Multiple Clinical Studies in China and Abroad, with Promising Efficacy in Various RAS-mutant Solid Tumors
Delete
No.7 Disclosure 2026/09/24 17:37
取締役一覧と役割
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Delete
No.6 Disclosure 2026/09/24 17:31
取締役・重要な執行役員の異動
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Delete
No.5 Disclosure 2026/09/23 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT Disclosure Arrangements for Clinical Data from Studies of GFH375 and GFH276
Delete
No.4 Disclosure 2026/09/22 09:00
Unusual Price/Turnover Movements - Qualified
ANNOUNCEMENT PURSUANT TO RULE 13.10 OF THE LISTING RULES
Delete
No.3 Disclosure 2026/09/21 09:06
事業の状況
VOLUNTARY ANNOUNCEMENT Announcement on the Progress of Share Repurchase
Delete
No.2 Disclosure 2026/09/16 17:30
中間報告書
2026 Interim Report
Delete
No.1 Disclosure 2026/09/15 09:00
事業の状況
VOLUNTARY ANNOUNCEMENT Favorable Phase II Efficacy Data of GFH375 (Oral KRAS G12D Inhibitor) Monotherapy in Pretreated NSCLC Presented in Oral Session at 2026 World Conference on Lung Cancer (WCLC)
Delete

Write on the GenFleet Therapeutics (Shanghai) Inc. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English